[
  {
    "ts": "2026-01-15T11:50:00+00:00",
    "headline": "BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast Biopsy and Tissue Removal System, a state-of-the-art multi-modality breast biopsy system designed to provide clinicians with flexibility across breast imaging modalities in the diagnosis of breast disease.",
    "url": "https://finance.yahoo.com/news/bd-receives-fda-510-k-115000914.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "818b8ac2-e6a9-33fb-8eb9-422cb795f8d1",
      "content": {
        "id": "818b8ac2-e6a9-33fb-8eb9-422cb795f8d1",
        "contentType": "STORY",
        "title": "BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System",
        "description": "",
        "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast Biopsy and Tissue Removal System, a state-of-the-art multi-modality breast biopsy system designed to provide clinicians with flexibility across breast imaging modalities in the diagnosis of breast disease.",
        "pubDate": "2026-01-15T11:50:00Z",
        "displayTime": "2026-01-15T11:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/0821a7c6268cfce135c4974ccc3907b4",
          "originalWidth": 400,
          "originalHeight": 220,
          "caption": "BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Aqk7PYghd4l4ff.zPPa7NQ--~B/aD0yMjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0821a7c6268cfce135c4974ccc3907b4.cf.webp",
              "width": 400,
              "height": 220,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1ObydvOql.FfjN4OCpge5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0821a7c6268cfce135c4974ccc3907b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-receives-fda-510-k-115000914.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-receives-fda-510-k-115000914.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]